AAAAAA
Results: 1-25/41
Authors:
Roses, AD
Citation: Ad. Roses, The human medicine project has started: place your bets now, DRUG DISC T, 6(6), 2001, pp. 282-284
Authors:
Roses, AD
Citation: Ad. Roses, How will pharmacogenetics impact the future of research and development?, DRUG DISC T, 6(2), 2001, pp. 59-60
Authors:
White, F
Nicoll, JAR
Roses, AD
Horsburgh, K
Citation: F. White et al., Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion, NEUROBIOL D, 8(4), 2001, pp. 611-625
Authors:
Roses, AD
Citation: Ad. Roses, Pharmacogenetics, HUM MOL GEN, 10(20), 2001, pp. 2261-2267
Authors:
Scott, WK
Nance, MA
Watts, RL
Hubble, JP
Koller, WC
Lyons, K
Pahwa, R
Stern, MB
Colcher, A
Hiner, BC
Jankovic, J
Ondo, WG
Allen, FH
Goetz, CG
Small, GW
Masterman, D
Mastaglia, F
Laing, NG
Stajich, JM
Slotterbeck, B
Booze, MW
Ribble, RC
Rampersaud, E
West, SG
Gibson, RA
Middleton, LT
Roses, AD
Haines, JL
Scott, BL
Vance, JM
Pericak-Vance, MA
Citation: Wk. Scott et al., Complete genomic screen in parkinson disease - Evidence for multiple genes, J AM MED A, 286(18), 2001, pp. 2239-2244
Authors:
Martin, ER
Scott, WK
Nance, MA
Watts, RL
Hubble, JP
Koller, WC
Lyons, K
Pahwa, R
Stern, MB
Colcher, A
Hiner, BC
Jankovic, J
Ondo, WG
Allen, FH
Goetz, CG
Small, GW
Masterman, D
Mastaglia, F
Laing, NG
Stajich, JM
Ribble, RC
Booze, MW
Rogala, A
Hauser, MA
Zhang, FY
Gibson, RA
Middleton, LT
Roses, AD
Haines, JL
Scott, BL
Pericak-Vance, MA
Vance, JM
Citation: Er. Martin et al., Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease, J AM MED A, 286(18), 2001, pp. 2245-2250
Authors:
Roses, AD
Citation: Ad. Roses, 2025: The practice of neurology - Back from the future, ARCH NEUROL, 58(11), 2001, pp. 1766-1767
Authors:
Haines, JL
Bailey, LR
Grubber, JM
Hedges, D
Hall, JL
West, S
Santoro, L
Kemmerer, B
Saunders, AM
Roses, AD
Small, GW
Scott, WK
Conneally, PM
Vance, JM
Pericak-Vance, MA
Citation: Jl. Haines et al., A genomic search for Alzheimer's disease genes, ALZHEIMER'S DISEASE, 2001, pp. 33-43
Authors:
Small, GW
Ercoli, LM
Silverman, DHS
Huang, SC
Bookheimer, SY
Lavretsky, H
Miller, K
Siddarth, P
Mazziotta, JC
Saunders, AM
Pericak-Vance, MA
Roses, AD
Barrio, JR
Phelps, ME
Citation: Gw. Small et al., Influence of apoE genotype and PET brain imaging on preclinical predictionof Alzheimer's disease, ALZHEIMER'S DISEASE, 2001, pp. 193-203
Authors:
Grubber, JM
Saunders, AM
Yamaoka, LH
Scott, WK
Martin, ER
Hill, DM
Standen, CL
Conneally, PM
Small, GW
Lai, EH
Gilbert, JR
Roses, AD
Haines, JL
Pericak-Vance, MA
Citation: Jm. Grubber et al., Analysis of chromosome 12 candidate genes in late-onset Alzheimer disease, ALZHEIM REP, 3(4), 2000, pp. 221-226
Authors:
Roses, AD
Citation: Ad. Roses, Idiosyncratic reactions to drugs: Can medicine response profiles provide adynamic drug surveillance system?, CLIN CH L M, 38(9), 2000, pp. 815-818
Authors:
Wilkins, MR
Roses, AD
Clifford, CP
Citation: Mr. Wilkins et al., Pharmacogenetics and the treatment of cardiovascular disease, HEART, 84(4), 2000, pp. 353-354
Authors:
Riley, KP
Snowdon, DA
Saunders, AM
Roses, AD
Mortimer, JA
Nanayakkara, N
Citation: Kp. Riley et al., Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study, J GERONT B, 55(2), 2000, pp. S69-S75
Authors:
Horsburgh, K
McCulloch, J
Nilsen, M
Roses, AD
Nicoll, JAR
Citation: K. Horsburgh et al., Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia, EUR J NEURO, 12(12), 2000, pp. 4309-4317
Authors:
Saunders, AM
Trowers, MK
Shimkets, RA
Blakemore, S
Crowther, DJ
Mansfield, TA
Wallace, DM
Strittmatter, WJ
Roses, AD
Citation: Am. Saunders et al., The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection, BBA-MOL BAS, 1502(1), 2000, pp. 85-94
Authors:
Martin, ER
Gilbert, JR
Lai, EH
Riley, J
Rogala, AR
Slotterbeck, BD
Sipe, CA
Grubber, JM
Warren, LL
Conneally, PM
Saunders, AM
Schmechel, DE
Purvis, I
Pericak-Vance, MA
Roses, AD
Vance, JM
Citation: Er. Martin et al., Analysis of association at single nucleotide polymorphisms in the APOE region, GENOMICS, 63(1), 2000, pp. 7-12
Authors:
Pericak-Vance, MA
Grubber, J
Bailey, LR
Hedges, D
West, S
Santoro, L
Kemmerer, B
Hall, JL
Saunders, AM
Roses, AD
Small, GW
Scott, WK
Conneally, PM
Vance, JM
Haines, JL
Citation: Ma. Pericak-vance et al., Identification of novel genes in late-onset Alzheimer's disease, EXP GERONT, 35(9-10), 2000, pp. 1343-1352
Authors:
Chapman, S
Sabo, T
Roses, AD
Michaelson, DM
Citation: S. Chapman et al., Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice, NEUROSCIENC, 97(3), 2000, pp. 419-424
Authors:
Sabo, T
Lomnitski, L
Nyska, A
Beni, S
Maronpot, RR
Shohami, E
Roses, AD
Michaelson, DM
Citation: T. Sabo et al., Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities, NEUROSCIENC, 101(4), 2000, pp. 879-884
Authors:
Horsburgh, K
McCulloch, J
Nilsen, M
McCracken, E
Large, C
Roses, AD
Nicoll, JAR
Citation: K. Horsburgh et al., Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice, J CEREBR B, 20(3), 2000, pp. 458-462
Authors:
Roses, AD
Citation: Ad. Roses, Causes or consequences of inflammation and pathological signs of Alzheimerdisease - Commentary, NEUROBIOL A, 21(3), 2000, pp. 423-425
Authors:
Roses, AD
Citation: Ad. Roses, Pharmacogenetics and future drug development and delivery, LANCET, 355(9212), 2000, pp. 1358-1361
Authors:
Gonzalez, I
Ohsawa, N
Singer, RH
Devillers, M
Ashizawa, T
Balasubramanyam, A
Cooper, TA
Khajavi, M
Lia-Baldini, AS
Miller, G
Philips, AV
Timchenko, LT
Waring, J
Yamagata, H
Barbet, JP
Klesert, TR
Tapscott, SJ
Roses, AD
Wagner, M
Baiget, M
Martorell, L
Browne, GB
Eymard, B
Gourdon, G
Junien, C
Seznec, H
Carey, N
Gosling, M
Maire, P
Gennarelli, M
Sato, S
Ansved, T
Kvist, U
Eriksson, M
Furling, D
Chen, EJ
Housman, DE
Luciano, B
Siciliano, M
Spring, N
Shimizu, M
Eddy, E
Morris, GE
Krahe, R
Furuya, H
Adelman, J
Pribnow, D
Furutama, D
Mathieu, J
Hilton-Jones, D
Kinoshita, M
Abbruzzese, C
Sinden, RR
Wells, RD
Pearson, CE
Kobayashi, T
Johansson, A
Salvatori, S
Perryman, B
Swanson, MS
Gould, FK
Harris, SE
Johnson, K
Mitchell, AM
Monckton, DG
Winchester, CL
Antonini, G
Day, JW
Liquori, C
Ranum, LPW
Westerlaken, J
Wieringa, B
Griffith, JD
Michalowski, S
Moore, H
Hamshere, M
Korade, Z
Thornton, CA
Jaeger, H
Lehmann, F
Moorman, JR
Mounsey, JP
Mahadevan, MS
Citation: I. Gonzalez et al., New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1), NEUROLOGY, 54(6), 2000, pp. 1218-1221
Authors:
Roses, AD
Citation: Ad. Roses, Pharmacogenetics and the practice of medicine, NATURE, 405(6788), 2000, pp. 857-865
Authors:
Small, GW
Ercoli, LM
Silverman, DHS
Huang, SC
Komo, S
Bookheimer, SY
Lavretsky, H
Miller, K
Siddarth, P
Rasgon, NL
Mazziotta, JC
Saxena, S
Wu, HM
Mega, MS
Cummings, JL
Saunders, AM
Pericak-Vance, MA
Roses, AD
Barrio, JR
Phelps, ME
Citation: Gw. Small et al., Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease, P NAS US, 97(11), 2000, pp. 6037-6042